Skip to main content

Màrius Aguirre Canyadell

Institutions of which they are part

Senior researcher
Musculoskeletal Tissue Engineering
Vall Hebron Institut de Recerca

Màrius Aguirre Canyadell

Institutions of which they are part

Senior researcher
Musculoskeletal Tissue Engineering
Vall Hebron Institut de Recerca

Research lines

Bone formation

Research on bone regeneration in diseases such as bone necrosis of the femoral head, bone lengthening or bone reconstruction after tumour resection surgery.


We work in revascularization, growth factors and cell therapy. We have developed several animal models of injury on which we are applying different therapies.

IP: Màrius Aguirre Canyadell

Bone Regeneration

This research line seeks to promote bone regeneration using advanced cell therapy. Our alliance between biologists, engineers and clinical researchers enables us to develop new tissue engineering products that after thorough evaluation in the scopes of basic research and preclinical testing can then be applied in the human clinical setting.


Current Studies:


1. Autologous cell therapy with adult stem cells for osteonecrosis of the femoral head.

Osteonecrosis Clinical phase I-II study: We are currently conducting a comparative study between a product developed by our research group of advanced cell therapy in the context of osteonecrosis of the femoral head precollapse stage. It is a pioneering study at a national and international level by assessing the bone regenerative capability of this product compared to the classical treatment of core decompression.


2. Treatment of femoral head osteonecrosis with advanced cell therapy and biomaterials in an experimental sheep model.

Osteonecrosis preclinical study: We are evaluating mesenchymal stem cells expanded ex-vivo associated with different scaffolds and BMP in osteonecrosis of the femoral head in an ovine model. We are evaluating the different  osteoconductive, osteoinductive and osteogenerative components to optimize the best biologic for the treatment of femoral head necrosis.


3. Experimental study of "in vivo" expanded adult stem cell therapy .

Critical size defect preclinical study:  We are evaluating mesenchymal stem cells expanded ex-vivo in a critical segmental defect in an ovine model.

IP: Màrius Aguirre Canyadell, Roberto Vélez Villa

Projects

ACTUALIZACIÓN DE EQUIPAMIENTOS DE ALTA TECNOLOGIA PARA LA PLATAFORMA DE IMAGEN PRECLINICA. ADQUISICION DE UN EQUIPO DE ULTRASONIDOS DE INVESTIGACION PRECLINICA

IP: Inmaculada Fuentes Camps
Collaborators: Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Francesc Bosch Albareda, Victor Franco Puntes, José Raul Herance Camacho, Jordi Giralt López de Sagred, Màrius Aguirre Canyadell, Xavier Serres Créixams, Simon Schwartz Navarro, Joaquim Mateo Valderrama, Mario Marotta Baleriola, Anna Rosell Novel, Joan Genescà Ferrer
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 108390
Reference: EQC2019-006322-P
Duration: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

TRASLACIÓN DE UN PRODUCTO DE INGENIERÍA TISULAR ALOGÉNICO CON MSC DE GELATINA DE WHARTON PARA EL TRATAMIENTO DE LA OSTEONECROSIS EN PACIENTES ONCOLÓGICOS PEDIÁTRICOS.

IP: Joaquim Vives Armengol
Collaborators: Roberto Vélez Villa, Nayana Joshi Jubert, Lluis Martorell Cedres, Maria Cristina Díaz de Heredia Rubio, Màrius Aguirre Canyadell, Irene Portas Torres, Raquel Cabrera Perez
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/01788
Duration: 01/01/2020 - 30/06/2024

ADVANCECAT: Acceleradora pel desenvolupament de Teràpies Avançades a Catalunya..

IP: Jordi Barquinero Mañez
Collaborators: Màrius Aguirre Canyadell
Funding agency: Agència Competitivitat Empresa Catalana ACCIO
Funding: 47221.52
Reference: COMRDI15-1-0013-08
Duration: 01/02/2016 - 31/01/2019

Anàlisi de la revitalització en empelts estructurals d’os criopreservat associat a penjoll periòstic vascularitzat. Model animal a rata

IP: Màrius Aguirre Canyadell
Collaborators: Roberto Vélez Villa
Funding agency: SOCIETAT CATALANA DE CIRURGIA
Funding: 12000
Reference: SCCOT-2014-01
Duration: 27/02/2014 - 26/02/2015

Related news

The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine

Related professionals

Maria Regina Codas

Maria Regina Codas

Senior researcher
Infectious Diseases
Read more
Silvina Andrea Magnani

Silvina Andrea Magnani

Research technician
Infectious Diseases
Read more
Rucsanda Pinteac

Rucsanda Pinteac

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Annabelle Parent

Annabelle Parent

Research technician
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.